Intensive Instruction on the Use of Aricept

Alzheimer's Type Dementia Clinical Trial

Official title:
A Study About the Impact of Intensive Instruction on the Use of Aricept and the Reasons for Discontinuation in Patients With Alzheimer's Disease

Status Completed

Clinical Trial Summary

The purpose of this study is to examine the influence of the instruction on the use of Aricept with educational brochure on the 48-week medication persistence and to assess the reasons for discontinuation.

Clinical Trial Description

To examine the influence of the instruction on the use of Aricept with educational brochure comparing to the ordinary instruction on the 48-week medication persistence and to assess the reasons for discontinuation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01972204
Study type	Interventional
Source	Mirai Iryo Research Center, Inc.
Contact
Status	Completed
Phase	N/A
Start date	September 2013
Completion date	August 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01404169` - A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease	Phase 3
Recruiting	`NCT05397639` - Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type	Phase 3
Completed	`NCT01539031` - Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease	Phase 3
Completed	`NCT01276353` - A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia	Phase 2
Completed	`NCT03732053` - The Effectiveness of Global Postural Reeducation on Alzheimer Disease Patients	N/A
Terminated	`NCT02020356` - Music Therapy in Alzheimer's Disease	N/A